Table 1. TSY-1 induced changes of expression in telomere associated genes in HL-60, PBMCs and HSCs.
Telomere Maintenance | Telomere Associated Complex | Telomere Regulation | Other Telomerase-associated Genes | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Target | HL60 | PBMCs | HSCs | Gene Target | HL60 | PBMCs | HSCs | Gene Target | HL60 | PBMCs | HSCs | Gene Target | HL60 | PBMCs | HSCs |
DCLRE1C | −1.37 | 1.15 | −1.33 | RAP1A | 1.11 | −1.10 | 1.10 | TGFB1 | 1.32 | −1.08 | 1.12 | ATM | −1.28 | 1.14 | 1.34 |
HSPA1L | 4.52 | 5.74 | 2.85 | ACD | −1.67 | 1.55 | 1.49 | SSB | −1.76 | 1.04 | 1.17 | CDK2 | −2.59 | 1.06 | 1.00 |
MRE11A | −2.14 | 1.14 | 1.08 | POT1 | 1.01 | 1.38 | −1.32 | SP1 | 1.07 | 1.05 | −1.06 | CHEK1 | −1.73 | 1.83 | −1.48 |
NBN | 1.01 | 1..59 | −1.05 | TINF2 | 1.08 | −1.01 | −1.73 | SART1 | −1.24 | 1.02 | 1.37 | CHEK2 | −2.10 | 1.06 | −1.12 |
PARP1 | −2.22 | 1.10 | −1.28 | TERF1 | −1.02 | −1.57 | −1.26 | RB1 | 1.14 | 1.03 | 1.39 | HAT1 | −1.36 | 1.34 | 1.20 |
PIF1 | 1.36 | 1.69 | 2.05 | TERF2 | −1.13 | 1.11 | 1.08 | RAPGEF1 | 1.25 | −1.01 | 1.59 | HNRNPA2B1 | −2.08 | 1.11 | 1.03 |
PRKDC | −2.27 | −1.15 | −1.46 | GAR1 | −1.96 | 1.20 | −1.47 | RASSF1 | 1.96 | 1.23 | 1.05 | HNRNPD | −1.47 | 1.21 | 1.08 |
PTGES3 | −1.55 | 1.75 | 2.48 | NHP2 | −2.21 | −1.21 | −1.37 | TP53 | - | 1.04 | −1.14 | HSP90AA1 | −1.30 | 2.34 | 2.61 |
RAD50 | −1.23 | −1.12 | 1.05 | NOP10 | 1.01 | 1.55 | 1.14 | DCLRE1B | −1.76 | 1.01 | −1.13 | NCL | −2.08 | 1.05 | −1.26 |
RFC1 | −1.12 | −1.05 | −1.44 | TERT | −5.55 | 1.69 | 8.12 | KRIT1 | −1.37 | −1.07 | −1.08 | OBFC1 | 1.11 | −1.60 | −2.00 |
SMG6 | 1.11 | −1.07 | 1.24 | DKC1 | −1.24 | −1.17 | −1.24 | MYC | −4.58 | −1.40 | −1.32 | PURA | 1.64 | 1.31 | 2.35 |
TNKS2 | −1.23 | 1.13 | −1.06 | EME1 | −1.07 | −1.89 | 1.13 | SMAD3 | 1.25 | 1.69 | 8.12 | RAD17 | −1.13 | 1.05 | 1.19 |
RTEL1 | −2.34 | 1.05 | 1.22 | MSH2 | −1.57 | −1.17 | −1.35 | ABL1 | −1.27 | 1.18 | −1.24 | RIF1 | −1.30 | 1.11 | −1.56 |
TEP1 | 1.08 | 1.50 | 1.29 | MSH3 | −1.52 | 1.07 | −1.22 | AKT1 | −1.65 | 1.12 | −1.08 | SIRT2 | −1.53 | 1.19 | 1.24 |
TNKS | 1.03 | −1.14 | −1.15 | MUS81 | 1.26 | 1.05 | 1.21 | ATP5C1 | −1.37 | 1.08 | 1.17 | SIRT6 | −1.34 | 1.13 | 1.38 |
POT1 | 1.01 | 1.38 | −1.32 | PLK1 | −1.12 | −1.75 | −1.40 | BCL2 | −1.84 | 1.61 | −1.28 | SUN1 | 1.49 | 1.34 | 2.55 |
TINF2 | 1.08 | −1.01 | −1.73 | SLX4 | −1.06 | −1.10 | 1.04 | EGF | 1.67 | - | 2.32 | TP53BP1 | −1.86 | −1.08 | −1.17 |
TERF1 | −1.02 | −1.57 | −1.26 | ERCC1 | 1.05 | 1.28 | 1.19 | IGF1 | - | - | 4.51 | ||||
ERCC4 | −1.05 | 1.05 | 1.16 | ERCC4 | −1.05 | 1.05 | 1.16 | KRAS | −1.30 | 1.20 | −1.07 | ||||
TERF2 | −1.13 | 1.11 | 1.08 | TERF2 | −1.13 | 1.11 | 1.08 | MEN1 | −1.99 | 1.02 | −1.20 | ||||
TERF2IP | −1.02 | 1.01 | 1.10 | TERF2IP | −1.02 | 1.01 | 1.10 | PAX8 | −1.24 | −1.26 | 2.48 | ||||
DKC1 | −1.24 | −1.17 | −1.24 | PINX1 | −1.52 | 1.09 | −1.03 | ||||||||
TERT* | −5.55 | 1.69 | 8.12 | PPARG | 7.30 | −3.43 | 3.98 | ||||||||
MYC | −4.58 | −1.40 | −1.32 | PPP2R1A | −1.20 | 1.28 | 1.20 | ||||||||
ERCC1 | 1.05 | 1.28 | 1.19 | PPP2R1B | −1.42 | 1.41 | −1.32 | ||||||||
ACD | −1.67 | 1.55 | 1.49 | PRKCA | 1.95 | −1.43 | 1.91 | ||||||||
BLM | −1.97 | 1.17 | 1.13 | PRKCB | 1.93 | 1.00 | 1.21 |
The gene target that shows the most prominent differential effect between HL-60 (down regulation) and PBMCs / HSCs (up regulation) is TERT gene. Others (ACD, BLM, ATP5C1, BLM, CDK2, ERCC4, HAT1, HNRNPD, HSP90A1, MRE11A, PPP2R1A, PTGES3, RAD17, RTEL1, SART1, and SSB), have the same direction, but with minimal effect (mostly <2-fold change). PBMC: normal peripheral blood mononuclear cells, HSCs: CD34+ hematopoietic stem cells.